AN1 0.00% 0.8¢ anagenics limited

fujikura exercises its option to license cellm, page-3

  1. Osi
    16,366 Posts.
    lightbulb Created with Sketch. 201
    We need to think beyond the $440K licence fee receipt and consider how this test will enable midkine to sit as a co-marker for all the other cancer diagnostic tests out there.

    H U G E !

    cheers
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.